EDGAR Filing Documents for 0001144204-17-027739

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001144204-17-027739

Filing Date

2017-05-16

Accepted

2017-05-15 21:25:39

Documents

Period of Report

2017-05-15

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 6-K	v467025_6k.htm	6-K	12691
2	EXHIBIT 99.1	v467025_ex99-1.htm	EX-99.1	71357
3	EXHIBIT 99.2	v467025_ex99-2.htm	EX-99.2	776482
4	EXHIBIT 99.3	v467025_ex99-3.htm	EX-99.3	32492
5	GRAPHIC	graph.jpg	GRAPHIC	42390
6	GRAPHIC	image_001.jpg	GRAPHIC	4452
	Complete submission text file	0001144204-17-027739.txt		958984

Mailing Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018

Business Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018 (646) 350-0702

Akari Therapeutics Plc (Filer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: 6-K | Act: 34 | File No.: 001-36288 | Film No.: 17846858
SIC: 2834 Pharmaceutical Preparations